Sandu Pharmaceuticals Share Price
07 Aug, 2026 1:26 PM (IST)
Sandu Pharmaceuticals Performance
- Today's Low
- ₹40
- Today's High
- ₹41
- 52 Week Low
- ₹30
- 52 Week High
- ₹58
- Open Price₹41
- Previous Close₹39
- Volume535
- 50 DMA₹40.20
- 100 DMA₹40.00
- 200 DMA₹41.00
Sandu Pharmaceuticals Chart
Investment Returns
- Over 1 Month -4.96%
- Over 3 Month -4.92%
- Over 6 Month + 17.8%
- Over 1 Year -16.53%
Smart Investing Starts Here Start SIP with Sandu Pharmaceuticals for Steady Growth!
Sandu Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 15.9
- PEG Ratio
- 0.3
- Market Cap Cr
- 39
- P/B Ratio
- 0.9
- Average True Range
- 1.7
- EPS
- 2.5
- Dividend Yield
- 2
- MACD Signal
- -0.5
- RSI
- 43.44
- MFI
- 65.49
Latest Stock News Updates
Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve 1.To consider and approve the Standalone Unaudited Financial Results of the Company for the quarter ended 30th June, 2026. 2.To consider any other matter with the permission of the Chair
- BSE India
- 3 days 22 hours ago
Reconstitution of Committees of Board-Audit/Nomination/Stakeholders
- BSE India
- 3 weeks 5 days ago
1.Appointment of Dr Neeti Madan Kapre (DIN:06801264) as additional Non Executive Independent Director of the Company 2.Redesignation of Shri Balram Viswanathan (DIN: 10245195) as Chairman and Managing Director of the Company
- BSE India
- 3 weeks 5 days ago
Sandu Pharmaceuticals Financials
Sandu Pharmaceuticals Technicals
EMA & SMA
- Bearish Moving Average 6
- Bullish Moving Average 10
- 20 Day
- ₹39.80
- 50 Day
- ₹40.20
- 100 Day
- ₹40.00
- 200 Day
- ₹41.00
Resistance and Support
- R3 42.50
- R2 41.60
- R1 40.00
- S1 37.50
- S2 36.60
- S3 35.00
Sandu Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-08-11 | Quarterly Results | |
| 2026-07-11 | Others | Inter-alia, to consider 1. To place on record the demise of Shri Umesh B. Sandu Managing Director of the Company. 2. Approve the reconstitution of the Committees of the Board. 3.Other business matters |
| 2026-05-05 | Audited Results & Final Dividend | |
| 2026-02-06 | Quarterly Results | |
| 2025-11-12 | Quarterly Results |
About Sandu Pharmaceuticals
Sandu Pharmaceuticals is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name SANDU. e company has its manufacturing plant in Goa. View More- NSE Symbol
- SANDUPHQ
- BSE Symbol
- 524703
- ISIN
- INE751D01014
Similar Stocks to Sandu Pharmaceuticals
Popular Stocks
Sandu Pharmaceuticals FAQs
Sandu Pharmaceuticals share price is ₹39 As on 07 August, 2026 | 13:27
The Market Cap of Sandu Pharmaceuticals is ₹38.5 Cr As on 07 August, 2026 | 13:27
The P/E ratio of Sandu Pharmaceuticals is 15.9 As on 07 August, 2026 | 13:27
The PB ratio of Sandu Pharmaceuticals is 0.9 As on 07 August, 2026 | 13:27
The 52 week High & Low of Sandu Pharmaceuticals is ₹58.3/₹30 respectively As on 07 August, 2026 | 13:27
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.